-
1
-
-
0028158243
-
Nomenclature of systemic vasculitides. Proposal of an international consensus conference
-
A useful an important starting point for defining many different types of vasculitis
-
Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192 • A useful an important starting point for defining many different types of vasculitis.
-
(1994)
Arthritis Rheum
, vol.37
, pp. 187-192
-
-
Jennette, J.C.1
Falk, R.J.2
Andrassy, K.3
-
2
-
-
61449178959
-
EULAR Recommendations for the management of large vessel vasculitis
-
An evidence-based review of management of systemic vasculitis affecting large vessels
-
Mukhtyar C, Guillevin L, Cid MC, et al. EULAR Recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009;68:318-323 •• An evidence-based review of management of systemic vasculitis affecting large vessels.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 318-323
-
-
Mukhtyar, C.1
Guillevin, L.2
Cid, M.C.3
-
3
-
-
61449238213
-
EULAR Recommendations for the management of primary small and medium vessel vasculitis
-
An evidence-based review of management of systemic vasculitis affecting medium and small vessels
-
Mukhtyar C, Guillevin L, Cid MC, et al. EULAR Recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009;68:310-317 •• An evidence-based review of management of systemic vasculitis affecting medium and small vessels.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 310-317
-
-
Mukhtyar, C.1
Guillevin, L.2
Cid, M.C.3
-
4
-
-
39749124664
-
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis
-
BSR and BHPR Standards, Guidelines and Audit Working Group. (Oxford)
-
Lapraik C, Watts R, Bacon P, et al. BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 2007;46:1615-1616
-
(2007)
Rheumatology
, vol.46
, pp. 1615-1616
-
-
Lapraik, C.1
Watts, R.2
Bacon, P.3
-
6
-
-
0037173470
-
Polymyalgia rheumatica and giant-cell arteritis
-
DOI 10.1056/NEJMra011913
-
Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-271 (Pubitemid 34787634)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.4
, pp. 261-271
-
-
Salvarani, C.1
Cantini, F.2
Boiardi, L.3
Hunder, G.G.4
-
7
-
-
0001179656
-
Treatment of temporal arteritis with adrenal corticosteroids. Results in 55 cases in which lesions was proved at biopsy
-
Birkhead NC, Wagereor HP, Shick RM. Treatment of temporal arteritis with adrenal corticosteroids. Results in 55 cases in which lesions was proved at biopsy. J Am Med Assoc 1957;163:821-827
-
(1957)
J Am Med Assoc
, vol.163
, pp. 821-827
-
-
Birkhead, N.C.1
Wagereor, H.P.2
Shick, R.M.3
-
8
-
-
0142063451
-
Glucocorticoid therapy in GCA: Duration and adverse outcomes
-
Proven A, Gabriel SE. Glucocorticoid therapy in GCA: duration and adverse outcomes. Arthritis Rheum 2003;49:703-708
-
(2003)
Arthritis Rheum
, vol.49
, pp. 703-708
-
-
Proven, A.1
Gabriel, S.E.2
-
10
-
-
0034121147
-
A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: A one year followup study of 164 patients
-
Chevalet P, Barrer JH, Pottier P, et al. A randomized multicenter controlled trial using IV pulses of methylprednisolone in the initial treatment of simple forms of GCA:a one year follow up study of 164 pts. J Rheumatol 2000;27:1484-1491 (Pubitemid 30354049)
-
(2000)
Journal of Rheumatology
, vol.27
, Issue.6
, pp. 1484-1491
-
-
Chevalet, P.1
Barrier, J.-H.2
Pottier, P.3
Magadur-Joly, G.4
Pottier, M.-A.5
Hamidou, M.6
Planchon, B.7
El Kouri, D.8
Connan, L.9
Dupond, J.-L.10
De Wazieres, B.11
Dien, G.12
Duhamel, E.13
Grosbois, B.14
Jego, P.15
Le Strat, A.16
Capdeville, J.17
Letellier, P.18
Agron, L.19
-
11
-
-
33750370542
-
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: A double-blind, placebo-controlled, randomized prospective clinical trial
-
DOI 10.1002/art.22163
-
Mazlumzadeh M. Hunder GG, Easley KA, Calamia KT. Treatment of giant cell arteritis using induction therapy with high dose glucocorticosteroids: a double blind, placebo- controlled, randomized prospective clinical trial. Arthritis Rheum 2006;54:3310-3318 (Pubitemid 44622103)
-
(2006)
Arthritis and Rheumatism
, vol.54
, Issue.10
, pp. 3310-3318
-
-
Mazlumzadeh, M.1
Hunder, G.G.2
Easley, K.A.3
Calamia, K.T.4
Matteson, E.L.5
Griffing, W.L.6
Younge, B.R.7
Weyand, C.M.8
Goronzy, J.J.9
-
12
-
-
0347386450
-
Experience with infliximab as monotherapy for giant cell arteritis
-
Andonopoulos AP, Meimaris N, Daoussis D, et al. Experience with infliximab as monotherapy for giant cell arteritis. Ann Rheum Dis 2003;62:1116
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 1116
-
-
Andonopoulos, A.P.1
Meimaris, N.2
Daoussis, D.3
-
14
-
-
1842632375
-
Low-Dose Aspirin and Prevention of Cranial Ischemic Complications in Giant Cell Arteritis
-
DOI 10.1002/art.20171
-
Nesher G, Berkum Y, Mates M, et al. Low dose aspirin and prevention of cranial ischaemic complications in GCA. Arthritis Rheum 2004;50:1332-1337 (Pubitemid 38480844)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.4
, pp. 1332-1337
-
-
Nesher, G.1
Berkun, Y.2
Mates, M.3
Baras, M.4
Rubinow, A.5
Sonnenblick, M.6
-
15
-
-
52049107418
-
Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis
-
Narváez J, Bernad B, Gómez-Vaquero C, et al. Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis. Clin Exp Rheumatol 2008;26:S57-62
-
(2008)
Clin Exp Rheumatol
, vol.26
-
-
Narváez, J.1
Bernad, B.2
Gómez-Vaquero, C.3
-
17
-
-
0016500042
-
Daily and alternate day corticosteroid regimens in treatment of GCA: Comparison in a prospective study
-
Hunder GG, Sheps SG, Allen GL, Joyce JW. Daily and alternate day corticosteroid regimens in treatment of GCA: comparison in a prospective study. Ann Intern Med 1975;82:613-618
-
(1975)
Ann Intern Med
, vol.82
, pp. 613-618
-
-
Hunder, G.G.1
Sheps, S.G.2
Allen, G.L.3
Joyce, J.W.4
-
18
-
-
34547733910
-
Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis
-
DOI 10.1002/art.22754
-
Mahr AD, Jover JA, Spiera RF, et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 2007;56:2789-2797 • This paper pools the existing trials to demonstrate efficacy for methotrexate in GCA. (Pubitemid 47237299)
-
(2007)
Arthritis and Rheumatism
, vol.56
, Issue.8
, pp. 2789-2797
-
-
Mahr, A.D.1
Jover, J.A.2
Spiera, R.F.3
Hernandez-Garcia, C.4
Fernandez-Gutierrez, B.5
Lavalley, M.P.6
Merkel, P.A.7
-
19
-
-
0036090211
-
International Network for the Study of Systemic Vasculitides A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
-
Hoffman GS, Cid MC, Hellmann DB, et al. International Network for the Study of Systemic Vasculitides A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002;46:1309-1318
-
(2002)
Arthritis Rheum
, vol.46
, pp. 1309-1318
-
-
Hoffman, G.S.1
Cid, M.C.2
Hellmann, D.B.3
-
20
-
-
0034837581
-
A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA)
-
Spiera RF, Mitnick HJ, Kupersmith M, et al. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).Clin Exp. Rheumatol 2001;19:495-501 (Pubitemid 32894598)
-
(2001)
Clinical and Experimental Rheumatology
, vol.19
, Issue.5
, pp. 495-501
-
-
Spiera, R.F.1
Mitnick, H.J.2
Kupersmith, M.3
Richmond, M.4
Spiera, H.5
Peterson, M.G.E.6
Paget, S.A.7
-
21
-
-
0035895218
-
Combined treatment of giant-cell arteritis with methotrexate and prednisone: A randomized, double-blind, placebo-controlled trial
-
Jover JA, Hernández-García C, Morado IC, et al. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;134:106-114 (Pubitemid 32096337)
-
(2001)
Annals of Internal Medicine
, vol.134
, Issue.2
, pp. 106-114
-
-
Jover, J.A.1
Hernandez-Garcia, C.2
Morado, I.C.3
Vargas, E.4
Banares, A.5
Fernandez-Gutierrez, B.6
-
22
-
-
0022578244
-
Azathioprine in GCA - A double blind study
-
De Silva M, Hazleman BL. Azathioprine in GCA - A double blind study. Ann Rheum Dis 1986;45:136-138
-
(1986)
Ann Rheum Dis
, vol.45
, pp. 136-138
-
-
De Silva, M.1
Hazleman, B.L.2
-
23
-
-
34248351219
-
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: A randomized trial
-
Infliximab-GCA Study Group
-
Hoffman GS, Cid MC, Rendt-Zagar KE, et al. Infliximab-GCA Study Group. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 2007;146:621-630
-
(2007)
Ann Intern Med
, vol.146
, pp. 621-630
-
-
Hoffman, G.S.1
Cid, M.C.2
Rendt-Zagar, K.E.3
-
24
-
-
42449142953
-
A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects
-
DOI 10.1136/ard.2007.082115
-
Martínez-Taboada VM, Rodríguez-Valverde V, Carreño L, et al. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects. Ann Rheum Dis 2008;67:625-630 (Pubitemid 351571925)
-
(2008)
Annals of the Rheumatic Diseases
, vol.67
, Issue.5
, pp. 625-630
-
-
Martinez-Taboada, V.M.1
Rodriguez-Valverde, V.2
Carreno, L.3
Lopez-Longo, J.4
Figueroa, M.5
Belzunegui, J.6
Mola, E.M.7
Bonilla, G.8
-
25
-
-
0035674050
-
Treatment of longstanding active GCA with infliximab:report of four cases
-
Cantini F, Niccoli L, Salvarani C et al. Treatment of longstanding active GCA with infliximab:report of four cases Arthritis Rheum 2001;44:2933-2935
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2933-2935
-
-
Cantini, F.1
Niccoli, L.2
Salvarani, C.3
-
26
-
-
0344405706
-
Successful treatment of resistant giant cell arteritis with etanercept
-
DOI 10.1136/ard.62.4.373
-
Tan AL, Holdsworth J, Pease C, et al. Successful treatment of resistant giant cell arteritis with etanercept. Ann Rheum Dis 2003;62:373-374 (Pubitemid 36363453)
-
(2003)
Annals of the Rheumatic Diseases
, vol.62
, Issue.4
, pp. 373-374
-
-
Tan, A.L.1
Holdsworth, J.2
Pease, C.3
Emery, P.4
McGonagle, D.5
-
27
-
-
34447124357
-
Treatment of refractory temporal arteritis with adalimumab
-
DOI 10.1007/s10067-006-0375-2
-
Ahmed MM, Mubashir E, Hayat S, et al. Treatment of refractory temporal arteritis with adalimumab. Clin Rheumatol 2007;26:1353-1355 (Pubitemid 47034197)
-
(2007)
Clinical Rheumatology
, vol.26
, Issue.8
, pp. 1353-1355
-
-
Ahmed, M.M.1
Mubashir, E.2
Hayat, S.3
Fowler, M.4
Berney, S.M.5
-
28
-
-
21344460261
-
Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis
-
DOI 10.1136/ard.2005.036533
-
Bhatia A, Ell PJ, Edwards JC. Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis. Ann Rheum Dis 2005;64:1099-1100 (Pubitemid 40909539)
-
(2005)
Annals of the Rheumatic Diseases
, vol.64
, Issue.7
, pp. 1099-1100
-
-
Bhatia, A.1
Ell, P.J.2
Edwards, J.C.W.3
-
29
-
-
0028258530
-
Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate
-
Hoffman GS, Leavitt RY, Kerr GS, et al. Treatment of glucocorticoid- resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 1994;37:578-582 (Pubitemid 24115946)
-
(1994)
Arthritis and Rheumatism
, vol.37
, Issue.4
, pp. 578-582
-
-
Hoffman, G.S.1
Leavitt, R.Y.2
Kerr, G.S.3
Rottem, M.4
Sneller, M.C.5
Fauci, A.S.6
-
30
-
-
0041528396
-
Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis
-
Valsakumar AK, Valappil UC, Jorapur V, et al. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis. Rheumatol 2003;30:1793-1798 (Pubitemid 36962457)
-
(2003)
Journal of Rheumatology
, vol.30
, Issue.8
, pp. 1793-1798
-
-
Valsakumar, A.K.1
Valappil, U.C.2
Jorapur, V.3
Garg, N.4
Nityanand, S.5
Sinha, N.6
-
31
-
-
3142685997
-
Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis
-
DOI 10.1002/art.20300
-
Hoffman GS, Merkel PA, Brasington RD, et al. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004;50(7):2296-2304 (Pubitemid 38924409)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.7
, pp. 2296-2304
-
-
Hoffman, G.S.1
Merkel, P.A.2
Brasington, R.D.3
Lenschow, D.J.4
Liang, P.5
-
32
-
-
54349085648
-
Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: Long-term follow-up
-
Epub 2008 Aug 3
-
Molloy ES, Langford CA, Clark TM, et al. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 2008;67(11):1567-1569 [Epub 2008 Aug 3]
-
(2008)
Ann Rheum Dis
, vol.67
, Issue.11
, pp. 1567-1569
-
-
Molloy, E.S.1
Langford, C.A.2
Clark, T.M.3
-
33
-
-
0028897177
-
Treatment of resistant Takayasu's arteritis
-
Hoffman GS. Treatment of resistant Takayasu's arteritis. Rheum Dis Clin North Am 1995;21:73-80
-
(1995)
Rheum Dis Clin North Am
, vol.21
, pp. 73-80
-
-
Hoffman, G.S.1
-
34
-
-
0000772321
-
The kidney in polyarteritis nodosa
-
Davson J, Ball J, Platt R. The kidney in polyarteritis nodosa. QJM 1948;17:175-202
-
(1948)
QJM
, vol.17
, pp. 175-202
-
-
Davson, J.1
Ball, J.2
Platt, R.3
-
35
-
-
0025881485
-
Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients
-
The Cooperative Study Group for Polyarteritis Nodosa
-
Guillevin L, Jarrousse B, Lok C, et al. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa. J Rheumatol 1991;18:567-574
-
(1991)
J Rheumatol
, vol.18
, pp. 567-574
-
-
Guillevin, L.1
Jarrousse, B.2
Lok, C.3
-
36
-
-
0038122889
-
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
-
DOI 10.1056/NEJMoa020286
-
Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36-44 (Pubitemid 36765101)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.1
, pp. 36-44
-
-
Jayne, D.1
Rasmussen, N.2
Andrassy, K.3
Bacon, P.4
Tervaert, J.W.C.5
Dadoniene, J.6
Ekstrand, A.7
Gaskin, G.8
Gregorini, G.9
De Groot, K.10
Gross, W.11
Hagen, E.C.12
Mirapeix, E.13
Pettersson, E.14
Siegert, C.15
Sinico, A.16
Tesar, V.17
Westman, K.18
Pusey, C.19
-
37
-
-
12544253745
-
Etanercept plus standard therapy for Wegener's granulomatosis
-
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
-
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005;352:351-361
-
(2005)
N Engl J Med
, vol.352
, pp. 351-361
-
-
-
38
-
-
45849124232
-
British Society for Rheumatology, British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group; British Association of Dermatologists (BAD) BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
-
Chakravarty K, McDonald H, Pullar T, et al. British Society for Rheumatology, British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group; British Association of Dermatologists (BAD) BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. Rheumatology 2008;47:924-925
-
(2008)
Rheumatology
, vol.47
, pp. 924-925
-
-
Chakravarty, K.1
McDonald, H.2
Pullar, T.3
-
39
-
-
0030070089
-
Prognostic factors in polyarteritis Nodosa and Churg-Strauss syndrome: A prospective study in 342 patients
-
DOI 10.1097/00005792-199601000-00003
-
Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine 1996;75:17-28 (Pubitemid 26041085)
-
(1996)
Medicine
, vol.75
, Issue.1
, pp. 17-28
-
-
Guillevin, L.1
Lhote, F.2
Gayraud, M.3
Cohen, P.4
Jarrousse, B.5
Lortholary, O.6
Thibult, N.7
Casassus, P.8
-
40
-
-
0037440873
-
Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients
-
Guillevin L, Lhote F, Gayraud M, et al. Treatment of PAN and MPA with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty five patients. Arthiritis Rheum 2003;49:93-100 (Pubitemid 36286135)
-
(2003)
Arthritis Care and Research
, vol.49
, Issue.1
, pp. 93-100
-
-
Guillevin, L.1
Cohen, P.2
Mahr, A.3
Arene, J.-P.4
Mouthon, L.5
Puechal, X.6
Pertuiset, E.7
Gilson, B.8
Hamidou, M.9
Lanoux, P.10
Bruet, A.11
Ruivard, M.12
Vanhille, P.13
Cordier, J.-F.14
Agron, L.15
Alcalay, M.16
Arfi, S.17
Babinet, P.18
Bani Sadr, F.19
Bardet, M.20
Barrier, J.21
Blockmans, D.22
Bolla, G.23
Chevalet, P.24
Coronel, D.25
Delacroix-Szmania, I.26
El Dournovo, P.27
Dubois, A.28
El Kouri, D.29
Ergan, M.30
Esvant, H.31
Fior, R.32
Francois, S.33
Galanaud, P.34
Godeau, B.35
Houssiau, F.36
Hurault De Ligny, B.37
Karmochkine, M.38
Kerleau, J.M.39
Kyndt, X.40
Larroche, C.41
Lauque, D.42
Le Moal, S.43
Letellier, P.44
Lhote, F.45
Liote, F.46
Liozon, E.47
Liwartovski, J.48
Lobbedez, T.49
Merrien, D.50
Mornet, P.51
Palazzo, E.52
Patri, B.53
Pennaforte, J.L.54
Perret-Guillaume, C.55
Peureux, M.56
Philippe, P.57
Ponge, T.58
Pottier, M.A.59
Puechal, X.60
Puyoo, O.61
Quere, I.62
Rossert, J.63
Roux, S.64
Saraux, J.L.65
Soria, P.66
Stolear, J.C.67
Tazi, A.68
Tirot, D.69
Valcke, J.C.70
Viallard, J.F.71
Vidal, E.72
Wahl, D.73
Wissing, M.74
Zaegel, M.75
more..
-
41
-
-
34248526053
-
Churg-strauss syndrome with poor-prognosis factors: A prospective multicenter trail comparing glucocorticoids and six and twelve cyclophosphamide pulses in forty-eight patients
-
French Vasculitis Study Group
-
Cohen P, Pagnoux C, Mahr A, et al. French Vasculitis Study Group. Churg-strauss syndrome with poor-prognosis factors: a prospective multicenter trail comparing glucocorticoids and six and twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum 2007;57:686-693
-
(2007)
Arthritis Rheum
, vol.57
, pp. 686-693
-
-
Cohen, P.1
Pagnoux, C.2
Mahr, A.3
-
42
-
-
0031468852
-
Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: Comparison of steroids and oral or pulse cyclophosphamide in 25 patients
-
Gayraud M, Guillevin L, Cohen P, et al. Treatment of good-prognosis polyarteritis nodosa and Churg Strauss syndrome: comparison fo steroids and oral or pulse cyclophosphamide in 25 patients. French cooperative Study group for Vasculitides. Br J Rheumatol 1997;36:1290-1297 (Pubitemid 28025325)
-
(1997)
British Journal of Rheumatology
, vol.36
, Issue.12
, pp. 1290-1297
-
-
Gayraud, M.1
Guillevin, L.2
Cohen, P.3
Lhote, F.4
Cacoub, P.5
Deblois, P.6
Godeau, B.7
Ruel, M.8
Vidal, E.9
Pointud, M.10
Ducroix, J.P.11
Lassoued, S.12
Christoforov, B.13
Babinet, P.14
-
43
-
-
22244443649
-
Refractory polyarteritis nodosa successfully treated with infliximab
-
Al-Bishri J, le Riche N, Pope JE. Refractory polyarteritis nodosa successfully treated with infliximab. J Rheumatol 2005;32:1371-1373 (Pubitemid 40995399)
-
(2005)
Journal of Rheumatology
, vol.32
, Issue.7
, pp. 1371-1373
-
-
Al-Bishri, J.1
Le Riche, N.2
Pope, J.E.3
-
44
-
-
33746351498
-
Infliximab in a child with therapy-resistant systemic vasculitis
-
de Kort SW, van Rossum MA, ten Cate R. Infliximab in a child with therapy-resistant systemic vasculitis. Clin Rheumatol 2006;25:769-771
-
(2006)
Clin Rheumatol
, vol.25
, pp. 769-771
-
-
De Kort, S.W.1
Van Rossum, M.A.2
Ten Cate, R.3
-
45
-
-
33744782622
-
A new treatment for polyarteritis nodosa
-
DOI 10.1093/ndt/gfk082
-
Wu K, Throssell D. A new treatment for polyarteritis nodosa. Nephrol Dial Transplant 2006;21:2044 (Pubitemid 43834650)
-
(2006)
Nephrology Dialysis Transplantation
, vol.21
, Issue.6
, pp. 1710-1712
-
-
Wu, K.1
Throssell, D.2
-
47
-
-
0035742709
-
Transient and partial effect of high-dose intravenous immunoglobulin in polyarteritis nodosa
-
DOI 10.1159/000051741
-
Kroiss M, Hohenleutner U, Gruss C, et al. Transient and partial effect of high-dose intravenous immunoglobulin in polyarteritis nodosa. Dermatology 2001;203:188-189 (Pubitemid 34701586)
-
(2001)
Dermatology
, vol.203
, Issue.2
, pp. 188-189
-
-
Kroiss, M.1
Hohenleutner, U.2
Gruss, C.3
Glaessl, A.4
Landthaler, M.5
Stolz, W.6
-
48
-
-
0035671357
-
Successful treatment in two cases of steroid-dependent cutaneous polyarteritis nodosa with low-dose methotrexate
-
DOI 10.1159/000051785
-
Schartz NE, Alaoui S, Vignon-Pennamen MD, et al. Successful treatment in two cases of steroid-dependent cutaneous polyarteritis nodosa with low-dose methotrexate. Dermatology 2001;203:336-338 (Pubitemid 34045199)
-
(2001)
Dermatology
, vol.203
, Issue.4
, pp. 336-338
-
-
Schartz, N.E.C.1
Alaoui, S.2
Vignon-Pennamen, M.D.3
Cordoliani, F.4
Fermand, J.P.5
Morel, P.6
Rybojad, M.7
-
49
-
-
0033952713
-
Low-dose methotrexate controls a severe form of polyarteritis nodosa
-
Boehm I, Bauer R. Low-dose methotrexate controls a severe form of polyarteritis nodosa Arch. Dermatol 2000;136:167-169 (Pubitemid 30090753)
-
(2000)
Archives of Dermatology
, vol.136
, Issue.2
, pp. 167-169
-
-
Boehm, I.1
Bauer, R.2
-
50
-
-
0027998762
-
ERFOLGREICHE BEHANDLUNG EINER PANARTERIITIS NODOSA MIT METHOTREXAT LOW-DOSE-THERAPIE
-
DOI 10.1007/s001050050108
-
Brody M, Böhm I, Biwer E, Bauer R. Successful treatment of panarteritis nodosa with low-dose methotrexate therapy. Hautarzt 1994;45:476-479 (Pubitemid 24232643)
-
(1994)
Hautarzt
, vol.45
, Issue.7
, pp. 476-479
-
-
Brody, M.1
Bohm, I.2
Biwer, E.3
Bauer, R.4
-
51
-
-
0025940046
-
Cutaneous polyarteritis nodosa and Behçet's disease
-
Jorizzo JL, White WL, Wise CM, et al. cutaneous polyarteritis nodosa and Behçet's disease. J Am Acad Dermatol 1991;24:973-978
-
(1991)
J Am Acad Dermatol
, vol.24
, pp. 973-978
-
-
Jorizzo, J.L.1
White, W.L.2
Wise, C.M.3
-
52
-
-
0019278060
-
Combined therapy with methotrexate and prednisone in polyarteritis nodosa
-
Tannenbaum H. Combined therapy with methotrexate and prednisone in polyarteritis nodosa. Can Med Assoc J 1980;123:893-894 (Pubitemid 11146205)
-
(1980)
Canadian Medical Association Journal
, vol.123
, Issue.9
, pp. 893-894
-
-
Tannenbaum, H.1
-
54
-
-
67649231722
-
Drug targets in hepatits B virus infection
-
Stein LL, Loomba R. Drug targets in hepatits B virus infection. Infect Disord Drug Targets 2009;9(2):105-116
-
(2009)
Infect Disord Drug Targets
, vol.9
, Issue.2
, pp. 105-116
-
-
Stein, L.L.1
Loomba, R.2
-
55
-
-
0018770498
-
Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange
-
Lockwood C, Worledge S, Nicholas A, et al. Reversal of impaired splenic function in patients with nephritis or vaculitis (or both) by plasma exchange. N Engl J Med 1979;300:524-530 (Pubitemid 9167826)
-
(1979)
New England Journal of Medicine
, vol.300
, Issue.10
, pp. 524-530
-
-
Lockwood, C.M.1
Worlledge, S.2
Nicholas, A.3
-
56
-
-
24044478502
-
Hepatitis B virus-associated polyarteritis nodosa: Clinical characteristics, outcome, and impact of treatment in 115 patients
-
DOI 10.1097/01.md.0000180792.80212.5e
-
Guillevin L, Mahr A, Callard P, et al. French Vasculitis Study Group Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine 2005;84:313-322 (Pubitemid 41368484)
-
(2005)
Medicine
, vol.84
, Issue.5
, pp. 313-322
-
-
Guillevin, L.1
Mahr, A.2
Callard, P.3
Godmer, P.4
Pagnoux, C.5
Leray, E.6
Cohen, P.7
-
57
-
-
0025807181
-
Nationwide survey of Kawasaki disease and acute rheumatic fever
-
Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991;119:279-282
-
(1991)
J Pediatr
, vol.119
, pp. 279-282
-
-
Taubert, K.A.1
Rowley, A.H.2
Shulman, S.T.3
-
58
-
-
0028863033
-
The prevention of coronary artery aneurysm in Kawasaki disease: A meta-analysis on the efficacy of aspirin and immunoglobulin treatment
-
Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995;96:1057-1061
-
(1995)
Pediatrics
, vol.96
, pp. 1057-1061
-
-
Durongpisitkul, K.1
Gururaj, V.J.2
Park, J.M.3
Martin, C.F.4
-
59
-
-
0021702429
-
High-dose intravenous gammaglobulin for Kawasaki disease
-
Furusho K, Kamiya T, Nakano H, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984;2:1055-1058 (Pubitemid 15211522)
-
(1984)
Lancet
, vol.2
, Issue.8411
, pp. 1055-1058
-
-
Furusho, K.1
Kamiya, T.2
Nakano, H.3
-
61
-
-
0031441688
-
Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose
-
DOI 10.1016/S0022-3476(97)70038-6
-
Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 1997;131:888 (Pubitemid 28027615)
-
(1997)
Journal of Pediatrics
, vol.131
, Issue.6
, pp. 888-893
-
-
Terai, M.1
Shulman, S.T.2
-
62
-
-
7144235794
-
Coronary risk factors in acute Kawasaki disease: Correlation of serum immunoglobulin levels with coronary complications
-
Sawaji Y, Haneda N, Yamaguchi S, et al. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications. Acta Paediatr Jpn 1998;40:218-225 (Pubitemid 28292609)
-
(1998)
Acta Paediatrica Japonica (Overseas Edition)
, vol.40
, Issue.3
, pp. 218-225
-
-
Sawaji, Y.1
Haneda, N.2
Yamaguchi, S.3
Kajino, Y.4
Kishida, K.5
Seto, S.6
Konishi, N.7
Waki, K.8
Baba, K.9
Arisawa, K.10
Kamiya, T.11
Mori, C.12
-
63
-
-
1842502929
-
Early intravenous gamma-globulin treatment for Kawasaki disease: The nationwide surveys in Japan
-
DOI 10.1016/j.jpeds.2003.12.033
-
Muta H, Ishii M, Egami K, et al. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr 2004;144:496-499 (Pubitemid 38457354)
-
(2004)
Journal of Pediatrics
, vol.144
, Issue.4
, pp. 496-499
-
-
Muta, H.1
Ishii, M.2
Egami, K.3
Furui, J.4
Sugahara, Y.5
Akagi, T.6
Nakamura, Y.7
Yanagawa, H.8
Matsuishi, T.9
-
64
-
-
0942297988
-
Evaluation of the Efficacy of Treatment of Kawasaki Disease before Day 5 of Illness
-
DOI 10.1007/s00246-003-0558-4
-
Fong NC, Hui YW, Li CK, Chiu MC. Evaluation of the efficacy of treatment of Kawasaki disease before day 5 of illness. Pediatr Cardiol 2004;25:31-34 (Pubitemid 38140853)
-
(2004)
Pediatric Cardiology
, vol.25
, Issue.1
, pp. 31-34
-
-
Fong, N.C.1
Hui, Y.W.2
Li, C.K.3
Chiu, M.C.4
-
65
-
-
0025935353
-
Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities
-
Marasini M, Pongiglione G, Gazzolo D, et al. Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities. Am J Cardiol 1991;68:796-797
-
(1991)
Am J Cardiol
, vol.68
, pp. 796-797
-
-
Marasini, M.1
Pongiglione, G.2
Gazzolo, D.3
-
66
-
-
39049175106
-
General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC)
-
Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-15):1-48
-
(2006)
MMWR Recomm Rep
, vol.55
, Issue.RR-15
, pp. 1-48
-
-
Kroger, A.T.1
Atkinson, W.L.2
Marcuse, E.K.3
Pickering, L.K.4
-
67
-
-
16244390429
-
Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association
-
DOI 10.1542/peds.2004-2182
-
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young. Am Heart Assoc Pediatrics 2004;114:1708-1733 (Pubitemid 41754943)
-
(2004)
Pediatrics
, vol.114
, Issue.6
, pp. 1708-1733
-
-
Newburger, J.W.1
Takahashi, M.2
Gerber, M.A.3
Gewitz, M.H.4
Tani, L.Y.5
Burns, J.C.6
Shulman, S.T.7
Bolger, A.F.8
Ferrieri, P.9
Baltimore, R.S.10
Wilson, W.R.11
Baddour, L.M.12
Levison, M.E.13
Pallasch, T.J.14
Falace, D.A.15
Taubert, K.A.16
-
68
-
-
0028988292
-
Kawasaki disease in infants less than one year of age
-
Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr 1995;126:524-529
-
(1995)
J Pediatr
, vol.126
, pp. 524-529
-
-
Rosenfeld, E.A.1
Corydon, K.E.2
Shulman, S.T.3
-
69
-
-
8444247048
-
Acute management of Kawasaki disease
-
DOI 10.1016/j.ppedcard.2004.08.006, PII S1058981304000281
-
Dummer KB, Newburger JW. Acute management of Kawasaki disease. Prog Pediatr Cardiol 2004;19:129-135 (Pubitemid 39485650)
-
(2004)
Progress in Pediatric Cardiology
, vol.19
, Issue.2 SPEC.ISS.
, pp. 129-135
-
-
Dummer, K.B.1
Newburger, J.W.2
-
70
-
-
67649686861
-
Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: A meta-analysis of 862 children
-
Wooditch AC, Aronoff SC. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. J Pediatr 2006;149:336-341
-
(2006)
J Pediatr
, vol.149
, pp. 336-341
-
-
Wooditch, A.C.1
Aronoff, S.C.2
-
71
-
-
33747875063
-
A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcome
-
DOI 10.1016/j.jpeds.2006.05.025, PII S002234760600463X
-
Inoue Y, Okada Y, Shinohara M, et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr 2006;149:336-341 (Pubitemid 44308435)
-
(2006)
Journal of Pediatrics
, vol.149
, Issue.3
-
-
Inoue, Y.1
Okada, Y.2
Shinohara, M.3
Kobayashi, T.4
Kobayashi, T.5
Tomomasa, T.6
Takeuchi, K.7
Morikawa, A.8
-
72
-
-
33846995989
-
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease
-
Pediatric Heart Network Investigators. Pediatric Heart Network Investigators
-
Newburger JW, Sleeper LA, McCrindle BW, et al. Pediatric Heart Network Investigators. Pediatric Heart Network Investigators. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 2007;356:663-675
-
(2007)
N Engl J Med
, vol.356
, pp. 663-675
-
-
Newburger, J.W.1
Sleeper, L.A.2
McCrindle, B.W.3
-
73
-
-
0032411505
-
Intravenous gamma-globulin treatment and retreatment in Kawasaki disease
-
US/Canadian Kawasaki Syndrome Study Group
-
Burns JC, Capparelli EV, Brown JA, et al. US/Canadian Kawasaki Syndrome Study Group. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J 1998;17:1144-1148
-
(1998)
Pediatr Infect Dis J
, vol.17
, pp. 1144-1148
-
-
Burns, J.C.1
Capparelli, E.V.2
Brown, J.A.3
-
74
-
-
38849166744
-
Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease
-
DOI 10.1136/adc.2007.126144
-
Furukawa T, Kishiro M, Akimoto K, et al. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Arch Dis Child 2008;93:142-146 (Pubitemid 351204755)
-
(2008)
Archives of Disease in Childhood
, vol.93
, Issue.2
, pp. 142-146
-
-
Furukawa, T.1
Kishiro, M.2
Akimoto, K.3
Nagata, S.4
Shimizu, T.5
Yamashiro, Y.6
-
76
-
-
0036371306
-
Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?
-
Williams RV, Wilke VM, Tani LY, Minich LL. Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics 2002;109:E4
-
(2002)
Pediatrics
, vol.109
-
-
Williams, R.V.1
Wilke, V.M.2
Tani, L.Y.3
Minich, L.L.4
-
77
-
-
18844398919
-
Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate
-
DOI 10.1080/03009740510026328
-
Ahn SY, Kim DS. Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate. Scand J Rheumatol 2005;34:136-139 (Pubitemid 40694833)
-
(2005)
Scandinavian Journal of Rheumatology
, vol.34
, Issue.2
, pp. 136-139
-
-
Ahn, S.-Y.1
Kim, D.S.2
-
78
-
-
44949245186
-
Infliximab treatment in refractory Kawasaki syndrome
-
DOI 10.1007/s12098-008-0084-8
-
Girish M, Subramaniam G. Infliximab treatment in refractory Kawasaki syndrome. Indian J Pediatr 2008;75:521-522 (Pubitemid 351814605)
-
(2008)
Indian Journal of Pediatrics
, vol.75
, Issue.5
, pp. 521-522
-
-
Girish, M.1
Subramaniam, G.2
-
79
-
-
34247216142
-
Incomplete and atypical Kawasaki disease in a young infant: Severe, recalcitrant disease responsive to infliximab
-
DOI 10.1177/0009922806294842
-
O'Connor MJ, Saulsbury FT. Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab. Clin Pediatr (Phila) 2007;46:345-348 (Pubitemid 46609103)
-
(2007)
Clinical Pediatrics
, vol.46
, Issue.4
, pp. 345-348
-
-
O'Connor, M.J.1
Saulsbury, F.T.2
-
80
-
-
33748574875
-
Efficacy of infliximab in long-lasting refractory Kawasaki disease [2]
-
Zulian F, Zanon G, Martini G, et al. Efficacy of infliximab in long-lasting refractory Kawasaki disease. Clin Exp Rheumatol 2006;24:453 (Pubitemid 44363551)
-
(2006)
Clinical and Experimental Rheumatology
, vol.24
, Issue.4
, pp. 453
-
-
Zulian, F.1
Zanon, G.2
Martini, G.3
Mescoli, G.4
Milanesi, O.5
-
81
-
-
33746809371
-
The effect of TNFalpha blockade in complicated, refractory Kawasaki disease
-
DOI 10.1080/03009740600588228, PII W3747G517N340J14
-
Stenbøg EV, Windelborg B, Hørlyck A, Herlin T. The effect of TNFalpha blockade in complicated, refractory Kawasaki disease. Scand J Rheumatol 2006;35:318-321 (Pubitemid 44181186)
-
(2006)
Scandinavian Journal of Rheumatology
, vol.35
, Issue.4
, pp. 318-321
-
-
Stenbog, E.V.1
Windelborg, B.2
Horlyck, A.3
Herlin, T.4
-
82
-
-
20944437247
-
Infliximab treatment for refractory Kawasaki syndrome
-
DOI 10.1016/j.jpeds.2004.12.022
-
Burns JC, Mason WH, Hauger SB, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005;146:662-667 (Pubitemid 40616253)
-
(2005)
Journal of Pediatrics
, vol.146
, Issue.5
, pp. 662-667
-
-
Burns, J.C.1
Mason, W.H.2
Hauger, S.B.3
Janai, H.4
Bastian, J.F.5
Wohrley, J.D.6
Balfour, I.7
Shen, C.A.8
Michel, E.D.9
Shulman, S.T.10
Melish, M.E.11
-
83
-
-
17744411736
-
Initial intravenous gammaglobulin treatment failure in Kawasaki disease
-
Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105:E78
-
(2000)
Pediatrics
, vol.105
-
-
Wallace, C.A.1
French, J.W.2
Kahn, S.J.3
Sherry, D.D.4
-
84
-
-
0141924615
-
Longstanding obliterative panarteritis in Kawasaki disease: Lack of cyclosporin a effect
-
DOI 10.1542/peds.112.4.986
-
Kuijpers TW, Biezeveld M, Achterhuis A, et al. Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect. Pediatrics 2003;112:986-992 (Pubitemid 37248716)
-
(2003)
Pediatrics
, vol.112
, Issue.4
, pp. 986-992
-
-
Kuijpers, T.W.1
Biezeveld, M.2
Achterhuis, A.3
Kuipers, I.4
Lam, J.5
Hack, C.E.6
Becker, A.E.7
Van Der Wal, A.C.8
-
85
-
-
40949086903
-
Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin
-
Mori M. Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin. Nippon Rinsho 2008;66:349-354
-
(2008)
Nippon Rinsho
, vol.66
, pp. 349-354
-
-
Mori, M.1
-
86
-
-
34548144935
-
Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA- associated vasculitis -preliminary center experience
-
10591
-
Rihová Z, Jancová E, Merta M, et al. Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA- associated vasculitis -preliminary center experience. Prague Med Rep 2004;10591:64-68
-
(2004)
Prague Med Rep
, pp. 64-68
-
-
Rihová, Z.1
Jancová, E.2
Merta, M.3
-
87
-
-
23644455521
-
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis
-
DOI 10.1002/art.21142
-
De Groot K, Rasmussen N, Bacon PA, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005;52(8):2461-2469 (Pubitemid 41117433)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.8
, pp. 2461-2469
-
-
De Groot, K.1
Rasmussen, N.2
Bacon, P.A.3
Tervaert, J.W.C.4
Feighery, C.5
Gregorini, G.6
Gross, W.L.7
Luqmani, R.8
Jayne, D.R.W.9
-
88
-
-
0030993763
-
Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis
-
Adu D, Pall A, Luqmani RA, et al. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM 1997;90:401-409 (Pubitemid 27254196)
-
(1997)
QJM - Monthly Journal of the Association of Physicians
, vol.90
, Issue.6
, pp. 401-409
-
-
Adu, D.1
Pall, A.2
Luqmani, R.A.3
Richards, N.T.4
Howie, A.J.5
Emery, P.6
Michael, J.7
Savage, C.O.S.8
Bacon, P.A.9
-
89
-
-
0037097601
-
High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate
-
Reinhold-Keller E, Fink CO, Herlyn K, et al. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate. Arthritis Rheum 2002;47:326-332 (Pubitemid 34627702)
-
(2002)
Arthritis Care and Research
, vol.47
, Issue.3
, pp. 326-332
-
-
Reinhold-Keller, E.1
Fink, C.O.E.2
Herlyn, K.3
Gross, W.L.4
De Groot, K.5
-
90
-
-
0029946561
-
Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis
-
Dutch Co-Trimoxazole Wegener Study Group
-
Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim- sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996;335:16-20
-
(1996)
N Engl J Med
, vol.335
, pp. 16-20
-
-
Stegeman, C.A.1
Tervaert, J.W.2
De Jong, P.E.3
Kallenberg, C.G.4
-
91
-
-
34447285291
-
Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis
-
DOI 10.1681/ASN.2007010090
-
Jayne DR, Gaskin G, Rasmussen N, et al. European Vasculitis Study Group. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007;18:2180-2188 (Pubitemid 47041083)
-
(2007)
Journal of the American Society of Nephrology
, vol.18
, Issue.7
, pp. 2180-2188
-
-
Jayne, D.R.W.1
Gaskin, G.2
Rasmussen, N.3
Abramowicz, D.4
Ferrario, F.5
Guillevin, L.6
Mirapeix, E.7
Savage, C.O.S.8
Sinico, R.A.9
Stegeman, C.A.10
Westman, K.W.11
Van Der Woude, F.J.12
Van Wijngaarden, R.A.F.D.L.13
Pusey, C.D.14
-
92
-
-
0033942210
-
Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease. activity
-
Jayne DR, Chapel H, Adu D, et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease. activity QJM 2000;93:433-439
-
(2000)
QJM
, vol.93
, pp. 433-439
-
-
Jayne, D.R.1
Chapel, H.2
Adu, D.3
-
93
-
-
0029964713
-
Intravenous immunoglobulin as sole therapy for systemic vasculitis
-
Jayne DR, Lockwood CM. I ntravenous immunoglobulin as sole therapy for systemic vasculitis. Br J Rheumatol 1996;35(11):1150-1153 (Pubitemid 26397615)
-
(1996)
British Journal of Rheumatology
, vol.35
, Issue.11
, pp. 1150-1153
-
-
Jayne, D.R.W.1
Lockwood, C.M.2
-
94
-
-
0035140886
-
Cryoglobulinaemic vasculitis caused by intravenous immunoglobulin treatment
-
Odum J, D'Costa D, Freeth M, et al. Cryoglobulinaemic vasculitis caused by intravenous immunoglobulin treatment. Nephrol Dial Transplant 2001;16(2):403-406 (Pubitemid 32123936)
-
(2001)
Nephrology Dialysis Transplantation
, vol.16
, Issue.2
, pp. 403-406
-
-
Odum, J.1
D'Costa, D.2
Freeth, M.3
Taylor, D.4
Smith, N.5
MacWhannell, A.6
-
97
-
-
0037447483
-
Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: Extended follow-up and rate of relapse
-
DOI 10.1016/S0002-9343(03)00077-9
-
Langford CA, Talar-Williams C, Barron KS, Sneller MC. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse. Am J Med 2003;114:463-469 (Pubitemid 36515108)
-
(2003)
American Journal of Medicine
, vol.114
, Issue.6
, pp. 463-469
-
-
Langford, C.A.1
Talar-Williams, C.2
Barron, K.S.3
Sneller, M.C.4
-
98
-
-
1542288825
-
Prospective Study of TNFalpha Blockade with Infliximab in Anti-Neutrophil Cytoplasmic Antibody-Associated Systemic Vasculitis
-
DOI 10.1097/01.ASN.0000114554.67106.28
-
Booth A, Harper L, Hammad T, et al. Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 2004;15:717-721 (Pubitemid 38294802)
-
(2004)
Journal of the American Society of Nephrology
, vol.15
, Issue.3
, pp. 717-721
-
-
Booth, A.1
Harper, L.2
Hammad, T.3
Bacon, P.4
Griffith, M.5
Levy, J.6
Savage, C.7
Pusey, C.8
Jayne, D.9
-
99
-
-
34447323863
-
German network of rheumatic diseases. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis
-
Metzler C, Miehle N, Manger K, et al. German network of rheumatic diseases. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford) 2007;46:1087-1091
-
(2007)
Rheumatology (Oxford)
, vol.46
, pp. 1087-1091
-
-
Metzler, C.1
Miehle, N.2
Manger, K.3
-
100
-
-
34447302857
-
Leflunomide versus methotrexate in Wegener's granulomatosis
-
DOI 10.1093/rheumatology/kem050
-
Jayne D. Leflunomide versus methotrexate in Wegener's granulomatosis. Editorial. Rheumatology 2007;46:1047-1048 (Pubitemid 47050600)
-
(2007)
Rheumatology
, vol.46
, Issue.7
, pp. 1047-1048
-
-
Jayne, D.1
-
101
-
-
1842628929
-
Mycophenolate Mofetil for Remission Maintenance in the Treatment of Wegener's Granulomatosis
-
Langford CA, Talar-Williams C, Sneller MC. Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum 2004;51:278-328 (Pubitemid 38468715)
-
(2004)
Arthritis Care and Research
, vol.51
, Issue.2
, pp. 278-283
-
-
Langford, C.A.1
Talar-Williams, C.2
Sneller, M.C.3
-
102
-
-
33344473052
-
Mycofenolate mofetil in anti-neutrophil associated systemic vasculitis
-
Koulaki M, Jayne DR. Mycofenolate mofetil in anti-neutrophil associated systemic vasculitis. Nephron Clin Pract 2006;102:c100-7
-
(2006)
Nephron Clin Pract
, vol.102
-
-
Koulaki, M.1
Jayne, D.R.2
-
103
-
-
58149180323
-
Azathioprine or methotrexate maintenance for ANCA-associated vasculitis
-
For the French Vasculitis Study Group
-
Pagnoux C, Mahr A, Hamidou MA, et al. For the French Vasculitis Study Group. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. NEJM 2008;359:2790-2803
-
(2008)
NEJM
, vol.359
, pp. 2790-2803
-
-
Pagnoux, C.1
Mahr, A.2
Hamidou, M.A.3
-
104
-
-
0030464106
-
Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis: Methotrexate versus trimethoprim/ sulfamethoxazole
-
de Groot K, Reinhold-Keller E, Tatsis E, et al. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis: methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 1996;39:2052-2061 (Pubitemid 127607906)
-
(1996)
Arthritis and Rheumatism
, vol.39
, Issue.12
, pp. 2052-2061
-
-
De Groot, K.1
Reinhold-Keller, E.2
Tatsis, E.3
Paulsen, J.4
Heller, M.5
Nolle, B.6
Gross, W.L.7
-
105
-
-
0033499210
-
A staged approach to the treatment of Wegener's granulomatosis: Induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance
-
DOI 10.1002/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E
-
Langford CA, Talar-Williams C, Barron KS, Sneller MC. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance. Arthritis Rheum 1999;42:2666-2673 (Pubitemid 30327189)
-
(1999)
Arthritis and Rheumatism
, vol.42
, Issue.12
, pp. 2666-2673
-
-
Langford, C.A.1
Talar-Williams, C.2
Barron, K.S.3
Sneller, M.C.4
-
106
-
-
0002737870
-
Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis
-
Stegeman CA, Tervaert JW, Sluiter WJ, et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120:12-17 (Pubitemid 24011495)
-
(1994)
Annals of Internal Medicine
, vol.120
, Issue.1
, pp. 12-17
-
-
Stegeman, C.A.1
Cohen Tervaert, J.W.2
Sluiter, W.J.3
Manson, W.L.4
De Jong, P.E.5
Kallenberg, C.G.M.6
-
107
-
-
3242768507
-
A case of Pneumocystis carinii pneumonia associated with low dose methotrexate treament for rheumatoid arthritis and trimethoprim- Sulphamethoxazole induced pancytopenia
-
Shimada T, Nishimura Y, Funada Y, et al. A case of pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis and trimethoprim-sulphamethoxazole induced pancytopenia. Arerugi 2004;53(6):575-581 (Pubitemid 38981159)
-
(2004)
Japanese Journal of Allergology
, vol.53
, Issue.6
, pp. 575-581
-
-
Shimada, T.1
Nishimura, Y.2
Funada, Y.3
Takenaka, K.4
Kobayashi, K.5
Urata, Y.6
Yosimura, S.7
Nishiuma, T.8
Satouchi, M.9
Yokoyama, M.10
-
108
-
-
33750945860
-
Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: A long-term followup study
-
DOI 10.1002/art.22168
-
Saadoun D, Resche-Rigon M, Thibault V, et al. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term follow up study. Arthritis Rheum 2006;54:3696-3706 (Pubitemid 44737183)
-
(2006)
Arthritis and Rheumatism
, vol.54
, Issue.11
, pp. 3696-3706
-
-
Saadoun, D.1
Resche-Rigon, M.2
Thibault, V.3
Piette, J.-C.4
Cacoub, P.5
-
109
-
-
0023819955
-
Epidemiology of Schonlein-Henoch purpura
-
Nielsen HE. Epidemiology of Schönlein-Henoch purpura. Acta Paediatr Scand 1988;77:125-131 (Pubitemid 18081556)
-
(1988)
Acta Paediatrica Scandinavica
, vol.77
, Issue.1
, pp. 125-131
-
-
Nielsen, H.E.1
-
110
-
-
0036232277
-
Henoch-Schönlein Purpura in adults: Outcome and prognostic factors
-
DOI 10.1097/01.ASN.0000013883.99976.22
-
Pillebout E, Thervet E, Hill G, et al. Henoch-Schönlein purpura in adults: outcome and prognostic factors. Am Soc Nephrol 2002;13:1271-1278 (Pubitemid 34441408)
-
(2002)
Journal of the American Society of Nephrology
, vol.13
, Issue.5
, pp. 1271-1278
-
-
Pillebout, E.1
Thervet, E.2
Hill, G.3
Alberti, C.4
Vanhille, P.5
Nochy, D.6
-
112
-
-
59649090122
-
Prevention and treatment of renal disease in Henoch-Schönlein purpura: A systematic review
-
Chartapisak W, Opastirakul S, Willis N, et al. Prevention and treatment of renal disease in Henoch-Schönlein purpura: a systematic review. Arch Dis Child 2009;94:132-137
-
(2009)
Arch Dis Child
, vol.94
, pp. 132-137
-
-
Chartapisak, W.1
Opastirakul, S.2
Willis, N.3
-
113
-
-
0346007910
-
Henoch-Schönlein purpura nephritis: Course of disease and efficacy of cyclophosphamide
-
DOI 10.1007/s00467-003-1315-x
-
Tarshish P, Bernstein J, Edelmann CM. Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatric Nephrology 2004;19:51-56 (Pubitemid 38088250)
-
(2004)
Pediatric Nephrology
, vol.19
, Issue.1
, pp. 51-56
-
-
Tarshish, P.1
Bernstein, J.2
Edelmann Jr., C.M.3
-
114
-
-
12344330217
-
Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis
-
DOI 10.1002/art.20718
-
Keogh KA, Wylam ME, Stone JH, Specks U. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005;52:262-268 (Pubitemid 40129256)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.1
, pp. 262-268
-
-
Keogh, K.A.1
Wylam, M.E.2
Stone, J.H.3
Specks, U.4
-
115
-
-
0037073001
-
Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients
-
Lamprecht P, Arbach O, Voswinkel J, et al. Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients. Dtsch Med Wochenschr 2002;127:1876-1880
-
(2002)
Dtsch Med Wochenschr
, vol.127
, pp. 1876-1880
-
-
Lamprecht, P.1
Arbach, O.2
Voswinkel, J.3
-
116
-
-
0036796830
-
Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitidis: An open pilot study on 10 patients
-
Bartolucci P, Ramanoelina J, Cohen P, et al. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford) 2002;41:1126-1132 (Pubitemid 35203539)
-
(2002)
Rheumatology
, vol.41
, Issue.10
, pp. 1126-1132
-
-
Bartolucci, P.1
Ramanoelina, J.2
Cohen, P.3
Mahr, A.4
Godmer, P.5
Le Hello, C.6
Guillevin, L.7
-
117
-
-
27444446509
-
Current state of tumour necrosis factor alpha blockade in Wegener's granulomatosis
-
DOI 10.1136/ard.2005.042416
-
Mukhtyar C, Luqmani R. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis. Ann Rheum Dis 2005;64:iv31-36 (Pubitemid 41532014)
-
(2005)
Annals of the Rheumatic Diseases
, vol.64
, Issue.SUPPL. 4
-
-
Mukhtyar, C.1
Luqmani, R.2
-
118
-
-
31944440872
-
Rituximab for refractory Wegener's granulomatosis: Report of a prospective, open-label pilot trial
-
DOI 10.1164/rccm.200507-1144OC
-
Keogh KA, Ytterberg SR, Fervenza FC, et al. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006;173:180-187 (Pubitemid 43187890)
-
(2006)
American Journal of Respiratory and Critical Care Medicine
, vol.173
, Issue.2
, pp. 180-187
-
-
Keogh, K.A.1
Ytterberg, S.R.2
Fervenza, F.C.3
Carlson, K.A.4
Schroeder, D.R.5
Specks, U.6
-
119
-
-
33750214245
-
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab
-
DOI 10.1093/rheumatology/kel098
-
Stasi R, Stipa E, Del Poeta G, et al. Observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) 2006;45:1432-1436 (Pubitemid 44605482)
-
(2006)
Rheumatology
, vol.45
, Issue.11
, pp. 1432-1436
-
-
Stasi, R.1
Stipa, E.2
Del Poeta, G.3
Amadori, S.4
Newland, A.C.5
Provan, D.6
-
120
-
-
34247486954
-
Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: A study on 8 patients
-
Brihaye B, Aouba A, Pagnoux C, et al. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients. Clin Exp Rheumatol 2007;25:S23-27 (Pubitemid 46656590)
-
(2007)
Clinical and Experimental Rheumatology
, vol.25
, Issue.1 SUPPL. 44
-
-
Brihaye, B.1
Aouba, A.2
Pagnoux, C.3
Cohen, P.4
Lacassin, F.5
Guillevin, L.6
-
121
-
-
20144368363
-
Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab
-
DOI 10.1111/j.1365-2796.2005.01494.x
-
Eriksson P. Nine patients with anti-neutrophil cytoplasmic antibody positive vasculitis successfully treated with rituximab. J Intern Med 2005;257:540-548 (Pubitemid 40776514)
-
(2005)
Journal of Internal Medicine
, vol.257
, Issue.6
, pp. 540-548
-
-
Eriksson, P.1
-
122
-
-
62549152024
-
Deoxyspergualin in relapsing and refractory Wegener's granulomatosis
-
Epub ahead of print
-
Flossmann O, Baslund B, Bruchfeld A, et al. Deoxyspergualin in relapsing and refractory Wegener's granulomatosis. Ann Rheum Dis 2008 [Epub ahead of print]
-
(2008)
Ann Rheum Dis
-
-
Flossmann, O.1
Baslund, B.2
Bruchfeld, A.3
-
123
-
-
1642545105
-
Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): An open study in 15 patients
-
DOI 10.1111/j.1523-1755.2004.00534.x
-
Schmitt WH, Hagen EC, Neumann I, et al. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 2004;65:1440-1448 (Pubitemid 38406986)
-
(2004)
Kidney International
, vol.65
, Issue.4
, pp. 1440-1448
-
-
Schmitt, W.H.1
Hagen, E.C.2
Neumann, I.3
Nowack, R.4
Flores-Suarez, L.F.5
Van Der Woude, F.J.6
-
124
-
-
9144241082
-
Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan
-
Muso E, Ito-Ihara T, Ono T, et al. Intravenous immunoglobulin (IVIg) therapy in myeloperoxidase (MPO)-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan. Jpn J Infect Dis 2004;57:S17-18 (Pubitemid 39545717)
-
(2004)
Japanese Journal of Infectious Diseases
, vol.57
, Issue.5
-
-
Muso, E.1
Ito-Ihara, T.2
Ono, T.3
Imai, E.4
Yamagata, K.5
Akamatsu, A.6
Suzuki, K.7
-
125
-
-
49149124643
-
Apparent response to anti-IgE therapy in two patients with refractory 'forme fruste' of Churg-Strauss syndrome
-
Pabst S, Tiyerili V, Grohé C. Apparent response to anti-IgE therapy in two patients with refractory 'forme fruste' of Churg-Strauss syndrome. Thorax 2008;63(8):747-748
-
(2008)
Thorax
, vol.63
, Issue.8
, pp. 747-748
-
-
Pabst, S.1
Tiyerili, V.2
Grohé, C.3
-
126
-
-
52049098285
-
A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome
-
Metzler C, Schnabel A, Gross WL, Hellmich B. A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome. Clin Exp Rheumatol 2008;26(3 Suppl 49):S35-40
-
(2008)
Clin Exp Rheumatol
, vol.26
, Issue.3 SUPPL. 49
-
-
Metzler, C.1
Schnabel, A.2
Gross, W.L.3
Hellmich, B.4
|